Primer | Primer sequence (5’–3’) | Target gene | References |
---|---|---|---|
intF | CCAAGCTCTCGGGTAACATC | ||
P2R | CCCGAGGCATAGACTGTA | ||
5CS | GGCATCCAAGCAGCAAG | variable region | |
3CS | AAGCAGACTTGACCTGA | ||
AACF | ATCTCATATCGTCGAGTGG | ||
AACR | TGCGTGTTCGCTCGAATGC | ||
AADAF | GCAGCGCAATGACATTCTTG | ||
AADAR | ATCCTTCGGCGCGATTTTG | ||
CATF | TTACTCTGGCTACTATCAC | ||
CATR | TGATGGCATAAGGCTCTAC | ||
KPC-F | CGTCTAGTTCTGCTGTCTTG | ||
KPC-R | CTTGTCATCCTTGTTAGGCG | ||
VIM-F | GATGGTGTTTGGTCGCATA | ||
VIM-R | CGAATGCGCAGCACCAG | ||
NDM-F | GGTTTGGCGATCTGGTTTTC | ||
NDM-R | CGGAATGGCTCATCACGATC | ||
OXA-23-like-F | CCGTCGTTTACGACATTCA | ||
OXA-23-like-R | AAAGAGCGCATTGCTTTGAT | ||
IMP-F | GGAATAGAGTGGCTTAAYTCTC | ||
IMP-R | GGTTTAAYAAAACAACCACC | ||
bfmS-F | ATATATGCGGGGCTGGTAATTC | ||
bfmS-R | ATGCAGGTGCTTTTTTATTGGT | ||
cusE-F | ATGCATGTTCTCTGGACTGATGTTGAC | ||
cusE-R | CGACTTGTACCGTGACCGTATCTTGATAAG | ||
bap-F | CGTTTCCTGGGTCTGATGTATT | ||
bap-R | GTTATTGAAGGCTTCTTTAGTG | ||
abal-F | GTGGCTCAAGACAGAGAATC | ||
abal-R | TCAATCATCATTGGTGGACC | This study |
Genes | CRAB (n = 219) | CSAB (n = 50) | |
---|---|---|---|
204 | 19 | 0 |
|
– | 15 | 31 | |
140 | 31 | 0.798 | |
– | 79 | 19 | |
193 | 5 | 0 |
|
– | 26 | 45 | |
170 | 24 | 0 |
|
– | 49 | 26 | |
218 | 0 | 0 |
|
– | 1 | 50 |
Antibiotics | CRAB (n = 219) | CSAB (n = 50) | |||
---|---|---|---|---|---|
No. | Rate (%) | No. | Rate (%) | ||
CAZ | 218 | 99.54 | 6 | 12.00 | 0.000 |
CIP | 217 | 99.09 | 6 | 12.00 | 0.000 |
TOB | 206 | 94.06 | 6 | 12.00 | 0.000 |
DOX | 216 | 98.63 | 6 | 12.00 | 0.000 |
SXT | 166 | 75.80 | 8 | 16.00 | 0.000 |
LVX | 175 | 79.91 | 5 | 10.00 | 0.000 |
AMK | 131 | 59.82 | 6 | 12.00 | 1.000 |
FEP | 169 | 77.17 | 6 | 12.00 | 0.384 |
MNO | 78 | 35.62 | 2 | 4.00 | 0.000 |
TGC | 11 | 5.02 | 0 | 0.00 | 0.226 |
COL | 3 | 1.37 | 0 | 0.00 | 1.000 |
Antibiotics | |||||
---|---|---|---|---|---|
No. | Rate (%) | No. | Rate (%) | ||
CAZ | 75 | 100 | 143 | 99.31 | 1.000 |
CIP | 75 | 100 | 142 | 98.61 | 0.548 |
TOB | 75 | 100 | 132 | 91.67 | 0.009 |
DOX | 74 | 98.67 | 142 | 98.61 | 1.000 |
SXT | 73 | 97.33 | 93 | 64.58 | 0.000 |
LVX | 62 | 82.67 | 113 | 78.47 | 0.462 |
AMK | 58 | 77.33 | 78 | 54.17 | 0.001 |
FEP | 44 | 58.67 | 125 | 86.81 | 0.000 |
MNO | 36 | 48 | 42 | 29.17 | 0.006 |
TGC | 1 | 1.33 | 10 | 6.94 | 0.103 |
COL | 1 | 1.33 | 2 | 1.39 | 1.000 |
Genes | |||
---|---|---|---|
75 | 129 | 0.003 |
|
– | 0 | 15 | |
53 | 87 | 0.134 | |
– | 22 | 57 | |
72 | 121 | 0.009 |
|
– | 3 | 23 | |
53 | 116 | 0.088 | |
– | 22 | 28 | |
75 | 143 | 1.000 | |
– | 0 | 1 |
Antibiotics | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
+ (n = 204) | – (n = 15) | + (n = 140) | – (n = 79) | + (n = 170) | – (n = 49) | + (n = 193) | – (n = 26) | |||||
MNO | 72 | 6 | 0.782 | 47 | 31 | 0.4 | 59 | 19 | 0.6 | 68 | 10 | 0.747 |
DOX | 201 | 15 | 1 | 139 | 77 | 0.296 | 168 | 48 | 0.534 | 191 | 25 | 0.317 |
SXT | 154 | 12 | 1 | 98 | 68 | 0.008 |
124 | 42 | 0.066 | 145 | 21 | 0.528 |
CIP | 202 | 15 | 1 | 139 | 78 | 1 | 168 | 49 | 1 | 192 | 25 | 0.224 |
LVX | 163 | 12 | 1 | 109 | 66 | 0.313 | 141 | 34 | 0.037 |
152 | 23 | 0.246 |
TOB | 191 | 15 | 0.607 | 129 | 77 | 0.142 | 161 | 45 | 0.494 | 185 | 21 | 0.011 |
AMK | 125 | 6 | 0.105 | 79 | 52 | 0.173 | 96 | 35 | 0.06 | 119 | 12 | 0.13 |
TGC | 11 | 0 | 1 | 9 | 2 | 0.335 | 9 | 2 | 1 | 11 | 0 | 0.369 |
CAZ | 203 | 15 | 1 | 139 | 79 | 1 | 169 | 49 | 1 | 192 | 26 | 1 |
FEP | 156 | 13 | 0.74 | 112 | 57 | 0.184 | 141 | 28 | 0 |
148 | 21 | 0.641 |
COL | 3 | 0 | 1 | 2 | 1 | 1 | 2 | 1 | 0.534 | 2 | 1 | 0.317 |
Oxford | ST | |||||||
3272 | 1 | 12 | 56 | 1 | 1 | 385 | 26 | |
Pasteur | ST | |||||||
2520 | 3 | 2 | 2 | 2 | 3 | 4 | 95 |